Tower Research Capital LLC (TRC) - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 18 filers reported holding AKARI THERAPEUTICS PLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q3 2016$7,000
+75.0%
853
+164.1%
0.00%
Q2 2016$4,000
-42.9%
323
-36.7%
0.00%
-100.0%
Q4 2015$7,000
-69.6%
510
-46.1%
0.00%
-50.0%
Q3 2015$23,0009470.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 7,941,867$1,443,0371.26%
Omnia Family Wealth, LLC 782,372$142,1570.11%
NEA Management Company, LLC 452,167$82,1590.01%
Hikari Power Ltd 130,821$240.00%
Bryn Mawr Capital Management, LLC 100,000$18,1700.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$5,4950.00%
MILLENNIUM MANAGEMENT LLC 261,192$470.00%
Renaissance Technologies 283,550$520.00%
LPL Financial LLC 134,453$24,4300.00%
JPMORGAN CHASE & CO 237$00.00%
View complete list of AKARI THERAPEUTICS PLC shareholders